CY1119460T1 - Μεθοδοι διατηρησης της στοματικης υγειας σε ζωα χρησιμοποιωντας παραγωγα μορφολινης - Google Patents

Μεθοδοι διατηρησης της στοματικης υγειας σε ζωα χρησιμοποιωντας παραγωγα μορφολινης

Info

Publication number
CY1119460T1
CY1119460T1 CY20171101075T CY171101075T CY1119460T1 CY 1119460 T1 CY1119460 T1 CY 1119460T1 CY 20171101075 T CY20171101075 T CY 20171101075T CY 171101075 T CY171101075 T CY 171101075T CY 1119460 T1 CY1119460 T1 CY 1119460T1
Authority
CY
Cyprus
Prior art keywords
morpholine
producers
animals
methods
oral health
Prior art date
Application number
CY20171101075T
Other languages
English (en)
Inventor
Hugo De Bruyn
Rolf Valter ATTOSTRÖM
Original Assignee
Maelor Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maelor Laboratories Limited filed Critical Maelor Laboratories Limited
Publication of CY1119460T1 publication Critical patent/CY1119460T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

Χρήση μιας ένωσης η οποία έχει τον τύπο (I) στην παρασκευή ενός φαρμάκου για την πρόληψη ή αντιμετώπιση μιας νόσου η οποία προκαλείται από βακτήρια του στόματος σε ένα ζώο όπου R1 είναι μια γραμμική ή διακλαδισμένη αλκυλική ομάδα η οποία περιέχει 8 έως 16 άτομα άνθρακα στην 2- ή 3-θέση του μορφολινο δακτυλίου, και R2 είναι μία γραμμική ή διακλαδισμένη αλκυλική ομάδα η οποία περιέχει 2 έως 10 άτομα άνθρακα, υποκατεστημένη με μία υδροξυ ομάδα εκτός της άλφα-θέσης, ή ένα φαρμακευτικώς αποδεκτό άλας αυτής. Μία καλλυντική μέθοδος πρόληψης ή μείωσης της χρώσης του στόματος σε ένα ζώο, η οποία περιλαμβάνει το στάδιο της έκθεσης της στοματικής κοιλότητας σε μία μορφολινο ένωση του γενικού.
CY20171101075T 2006-02-28 2017-10-12 Μεθοδοι διατηρησης της στοματικης υγειας σε ζωα χρησιμοποιωντας παραγωγα μορφολινης CY1119460T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0604018.2A GB0604018D0 (en) 2006-02-28 2006-02-28 Method
PCT/GB2007/000680 WO2007099302A2 (en) 2006-02-28 2007-02-27 Methods of maintaining oral health in animals using morpholine derivatives

Publications (1)

Publication Number Publication Date
CY1119460T1 true CY1119460T1 (el) 2018-03-07

Family

ID=36178958

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171101075T CY1119460T1 (el) 2006-02-28 2017-10-12 Μεθοδοι διατηρησης της στοματικης υγειας σε ζωα χρησιμοποιωντας παραγωγα μορφολινης

Country Status (12)

Country Link
US (5) US20110171143A1 (el)
EP (2) EP3156057B1 (el)
CY (1) CY1119460T1 (el)
DK (2) DK3156057T3 (el)
ES (2) ES2648218T3 (el)
GB (1) GB0604018D0 (el)
HU (2) HUE037203T2 (el)
LT (1) LT1988903T (el)
PL (2) PL1988903T3 (el)
PT (2) PT1988903T (el)
SI (1) SI1988903T1 (el)
WO (1) WO2007099302A2 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0604018D0 (en) * 2006-02-28 2006-04-05 Sinclair Pharmaceuticals Ltd Method
EP2990034A4 (en) * 2013-04-22 2017-04-26 Obshchestvo S Ogranichennoy Otvetstvennostyu "Nanobiotekh" Antiseptic veterinary formulation and methods for use thereof
IT201600130729A1 (it) 2016-12-23 2018-06-23 Lundbeck Pharmaceuticals Italy S P A Processo per la produzione degli intermedi del delmopinolo
IT201600130538A1 (it) 2016-12-23 2018-06-23 Lundbeck Pharmaceuticals Italy S P A Processo per la produzione del delmopinolo
IT201600130642A1 (it) 2016-12-23 2018-06-23 Lundbeck Pharmaceuticals Italy S P A Processo per la produzione di 2(3 alchilmorfolino)-etan-1-olo
IT201700076821A1 (it) 2017-08-24 2019-02-24 Lundbeck Pharmaceuticals Italy S P A Nuovo sale del delmopinolo
EP4096571A4 (en) 2020-01-31 2024-03-06 You First Services, Inc. METHOD FOR PRODUCING DELMOPINOL AND SALTS THEREOF
WO2023183879A1 (en) * 2022-03-23 2023-09-28 You First Services, Inc. Methods for irrigation using delmopinol and delmopinol salts

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE439011B (sv) * 1980-03-21 1985-05-28 Ferrosan Ab Morfolinoforeningar, kompositioner innehallande dessa och anvendning derav
US4329333A (en) 1980-11-24 1982-05-11 Arthur Barr Method for the oral treatment of dogs and other animals
US4894221A (en) * 1981-03-19 1990-01-16 Ab Ferrosan Method of treating plaque using morpholine compounds
US4975270A (en) * 1987-04-21 1990-12-04 Nabisco Brands, Inc. Elastomer encased active ingredients
EP0426826B1 (en) 1989-05-24 1994-04-27 Pharmacia AB Substituted isoxazolidines and isoxazolines
US5015485A (en) * 1989-05-30 1991-05-14 Nabisco Brands, Inc. Dog biscuits having a coating containing an inorganic pyrophosphate
US5082653A (en) * 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
US5085850A (en) * 1990-11-09 1992-02-04 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and metal salts
US5467741A (en) * 1992-08-20 1995-11-21 Booda Products, Inc. Dog chew toy for canine dental care and methods for making chew toy
US5329881A (en) * 1992-08-31 1994-07-19 Booda Products, Inc. Dog chew toy for canine dental care and methods for making chew toy
US6096328A (en) * 1997-06-06 2000-08-01 The Procter & Gamble Company Delivery system for an oral care substance using a strip of material having low flexural stiffness
US5976549A (en) * 1998-07-17 1999-11-02 Lewandowski; Joan Method to reduce bad breath in a pet by administering raw garlic
US7387774B2 (en) 1999-11-12 2008-06-17 The Procter & Gamble Co. Method of enhancing fluoridation and mineralization of teeth
US20010043941A1 (en) * 2000-03-23 2001-11-22 Hiep Huatan Oral formulations of medicaments
EP1136067A1 (en) * 2000-03-23 2001-09-26 Pfizer Limited Oral formulations of medicaments
CA2415068C (en) 2000-06-30 2009-03-10 The Procter & Gamble Company Oral compositions comprising antimicrobial agents
US20040115247A1 (en) * 2001-01-12 2004-06-17 Melman Steven A. Multi-functional dental composition
CN1149936C (zh) 2001-03-31 2004-05-19 朱招宠 一种猪皮狗咬胶的加工方法
AU2002311922A1 (en) 2001-05-15 2002-11-25 The Procter And Gamble Company Oral care compositions
US20040156884A1 (en) * 2003-02-10 2004-08-12 Brown Dale G. Emulsion impregnated rawhide chews with antimicrobially active chlorhexidine
US9554984B2 (en) * 2003-11-03 2017-01-31 Jaleva Pharmaceuticals, Llc Oral care compositions for topical application
AU2004308360B2 (en) * 2003-12-22 2012-02-16 Imrex, Inc. Methods and compositions for oral hygiene
WO2005097053A1 (en) * 2004-04-01 2005-10-20 Smithkline Beecham Corporation Dissolvable tooth whitening strip
US20060264497A1 (en) 2005-03-28 2006-11-23 Zeligs Michael A Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health
BRPI0502145A (pt) 2005-06-03 2007-01-23 Mauricio Duarte Da Conceicao enxaguatório para prevenção e tratamento da halitose
GB0523743D0 (en) * 2005-11-22 2005-12-28 Sinclair Pharmaceuticals Ltd Method
GB0600431D0 (en) * 2006-01-10 2006-02-15 Sinclair Pharmaceuticals Ltd Method
GB0604018D0 (en) * 2006-02-28 2006-04-05 Sinclair Pharmaceuticals Ltd Method
US9089108B2 (en) * 2007-06-29 2015-07-28 Redbarn Pet Products, Inc. Adhesion system for rawhide and meat chew for dogs
WO2018235038A1 (en) * 2017-06-21 2018-12-27 Beck Medical, Ltd. METHODS OF USING NASAL INSERTS FOR TREATMENTS

Also Published As

Publication number Publication date
WO2007099302A3 (en) 2008-06-19
HUE037203T2 (hu) 2018-08-28
GB0604018D0 (en) 2006-04-05
LT1988903T (lt) 2018-01-25
DK3156057T3 (da) 2024-01-29
WO2007099302A2 (en) 2007-09-07
ES2961931T3 (es) 2024-03-14
US20180064719A1 (en) 2018-03-08
EP3156057A3 (en) 2017-07-26
EP1988903B1 (en) 2017-08-23
PL1988903T3 (pl) 2018-02-28
PT3156057T (pt) 2023-12-07
EP3156057A2 (en) 2017-04-19
US20110268671A1 (en) 2011-11-03
US20190175607A1 (en) 2019-06-13
US20150231048A1 (en) 2015-08-20
SI1988903T1 (sl) 2017-12-29
US20110171143A1 (en) 2011-07-14
EP1988903A2 (en) 2008-11-12
ES2648218T3 (es) 2017-12-29
US10206928B2 (en) 2019-02-19
WO2007099302A8 (en) 2008-09-04
EP3156057B1 (en) 2023-10-04
PT1988903T (pt) 2017-11-30
DK1988903T3 (en) 2017-10-09
HUE065668T2 (hu) 2024-06-28
PL3156057T3 (pl) 2024-03-18
US11660300B2 (en) 2023-05-30

Similar Documents

Publication Publication Date Title
CY1119460T1 (el) Μεθοδοι διατηρησης της στοματικης υγειας σε ζωα χρησιμοποιωντας παραγωγα μορφολινης
CY1115117T1 (el) Παραγωγα υποκατεστημενων οξαζολιδινονων και η χρηση τους ως αναστολεις παραγοντα χα
CO6220933A2 (es) Formulaciones de dosis unitaria y metdods para el tratamiento de la trombosis con un inhibidor oral del facror xa
CY1113766T1 (el) Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
CY1106679T1 (el) Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα
CY1115738T1 (el) Κρυσταλλικα επιδιαλυτωμενα συμπλοκα των παραγωγων (1s)-1,5-anyδpo-1-c-(3-((φainyλ)meθυλ) φαινυλ)-d-γλουσιτολης με αλκοολες οπως αναστολεις sglt2 για τη θεραπευτικη αντιμετωπιση του διαβητη
CY1110392T1 (el) Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης
CY1111721T1 (el) Ακυλαμινοπυραζολια ως αναστολεις fgfr
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
GT200800189A (es) Derivados de amida y su aplicación para el tratamiento de enfermedades relacionadas con proteína-g
CY1107084T1 (el) Παραγωγα πυρρολοπυριδαζινης
CO5690585A2 (es) Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor
CY1112377T1 (el) Μεθοδος και συνθεσεις για τη θεραπευτικη aντιμετωπιση των αιματολογικων κακοηθειων
CY1114520T1 (el) Παραγωγο ινδολιζινης και χρηση αυτου για ιατρικους σκοπους
CY1119118T1 (el) Θεραπευτικος παραγων για τις διαταραχες της διαθεσης
ECSP12011880A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
CO5690599A2 (es) Derivados de 3-(4-aminofenil) tienopirimid-4-ona como antagonistas mch r1 para el tratamiento de obesidad, diabetes, depresion y ansiedad
AR059986A1 (es) Tratamiento de aves de corral para aumentar la tasa de conversion alimenticia o reducir la incidencia de ascitis
CY1113649T1 (el) Θεραπευτικα μεσα
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
CY1111980T1 (el) Παραγωγα του αμιδιου τα οποια φερουν ενα υποκαταστατο του κυκλοπροπυλαμινοκαρβονυλιου και χρησιμευουν ως αναστολεις κυτταροκινης
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
CY1111601T1 (el) Παραγωγα καρβοξαμιδιων της τριαζολοπυριδινης, η παρασκευη τους και η θεραπευτικη χρηση τους
CY1124346T1 (el) ΠΑΡΑΓΩΓΑ ΧΡΩΜΑΝΙΟΥ, ΙΣΟΧΡΩΜΑΝΙΟΥ ΚΑΙ ΔΙΥΔΡΟΪΣΟΒΕΝΖΟΦΟΥΡΑΝΙΟΥ ΩΣ mGluR2-APNHTIKOI ΑΛΛΟΣΤΕΡΙΚΟΙ ΔΙΑΜΟΡΦΩΤΕΣ, ΣΥΝΘΕΣΕΙΣ, ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ
CY1119483T1 (el) Θεραπευτικος παραγων για τις αγχωδεις διαταραχες